Want to see JP:9340 full AI Analyst Report?
Top Page
ASO INTERNATIONAL INC.
(9340)
Select Model
Select Model
Rating:80Outperform
Price Target:
¥925.00
▲(30.10% Upside)
Action:Reiterated
Date:08/10/26
The score is driven primarily by strong financial performance—especially the debt-free balance sheet, rising equity, and improved recent profitability—supported by a reasonable P/E and a solid dividend yield. Technical indicators are mildly positive but largely neutral, limiting additional upside contribution to the score.
Positive Factors
Debt-free balance sheet
Zero debt materially reduces leverage and refinancing risk, giving the company greater resilience through weaker periods. Growing equity and improving returns on equity indicate that the balance sheet is strengthening while the business continues to generate productive returns.
Negative Factors
Margins remain below earlier peaks
Although operating and net margins have recovered, remaining below earlier peaks suggests that the company has not fully restored its prior earnings efficiency. Persistent margin pressure could limit profit growth even if revenue continues expanding and may constrain reinvestment capacity.
Read all positive and negative factors
Positive Factors
Negative Factors
Debt-free balance sheet
Zero debt materially reduces leverage and refinancing risk, giving the company greater resilience through weaker periods. Growing equity and improving returns on equity indicate that the balance sheet is strengthening while the business continues to generate productive returns.
Read all positive factors
ASO INTERNATIONAL INC. (9340) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥7.94B
Dividend Yield3.23%
Average Volume (3M)12.79K
Price to Earnings (P/E)15.2
Beta (1Y)0.49
Revenue Growth9.74%
EPS Growth17.84%
CountryJP
Employees310
SectorHealthcare
Sector Strength45
IndustryMedical - Instruments & Supplies
Share Statistics
EPS (TTM)50.83
Shares Outstanding9,862,800
10 Day Avg. Volume6,300
30 Day Avg. Volume12,790
Financial Highlights & Ratios
PEG Ratio0.73
Price to Book (P/B)2.08
Price to Sales (P/S)1.62
P/FCF Ratio15.93
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)57.1
Revenue Forecast (FY)¥4.53B
ASO INTERNATIONAL INC. Business Overview & Revenue Model
Company Description
Established in 1982 and headquartered in Tokyo, Japan, ASO International, Inc. is a key player in the orthodontics sector, providing a comprehensive array of products and services. The company develops and supplies advanced systems for teeth align...
ASO INTERNATIONAL INC. Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
92
Very Positive
Cash Flow
74
Positive
| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 4.04B | 4.17B | 3.80B | 3.54B | 3.19B | 3.12B |
| Gross Profit | 1.80B | 1.84B | 1.70B | 1.59B | 1.43B | 1.42B |
| EBITDA | 758.53M | 770.19M | 706.97M | 593.08M | 495.07M | 551.61M |
| Net Income | 497.69M | 518.61M | 438.58M | 386.41M | 338.16M | 351.84M |
Balance Sheet | ||||||
| Total Assets | 3.47B | 3.74B | 3.33B | 3.19B | 2.83B | 2.19B |
| Cash, Cash Equivalents and Short-Term Investments | 1.86B | 1.93B | 1.95B | 1.90B | 1.73B | 1.29B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 300.06M |
| Total Liabilities | 385.82M | 495.16M | 401.87M | 424.73M | 360.71M | 640.16M |
| Stockholders Equity | 3.08B | 3.24B | 2.93B | 2.76B | 2.47B | 1.55B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 423.88M | 444.17M | 386.44M | 172.24M | 197.24M |
| Operating Cash Flow | 0.00 | 454.64M | 473.34M | 437.15M | 245.72M | 246.65M |
| Investing Cash Flow | 0.00 | -761.68M | -150.41M | -179.28M | -90.61M | -67.71M |
| Financing Cash Flow | 0.00 | -224.04M | -265.35M | -93.80M | 276.62M | -104.67M |
ASO INTERNATIONAL INC. Technical Analysis
Positive
711.00
Price Trends
746.74
Positive
709.94
Positive
700.99
Positive
Market Momentum
21.39
Positive
58.84
Neutral
34.68
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:9340, the sentiment is Positive. The current price of 711 is below the 20-day moving average (MA) of 798.10, below the 50-day MA of 746.74, and above the 200-day MA of 700.99, indicating a bullish trend. The MACD of 21.39 indicates Positive momentum. The RSI at 58.84 is Neutral, neither overbought nor oversold. The STOCH value of 34.68 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:9340.
ASO INTERNATIONAL INC. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥7.94B | 15.20 | ― | 3.23% | 9.74% | 17.84% | |
75 Outperform | ¥133.74B | 16.03 | 24.90% | 2.00% | 15.46% | 6.44% | |
73 Outperform | ¥54.53B | 12.65 | ― | 3.77% | 15.36% | 5.16% | |
71 Outperform | ¥7.76T | 30.14 | 26.25% | 1.27% | 12.65% | 32.11% | |
62 Neutral | ¥130.65B | 17.66 | 7.70% | 1.63% | 5.05% | 50.43% | |
54 Neutral | ¥24.00B | 22.03 | ― | 1.89% | 2.22% | -2.17% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
JP:9340
ASO INTERNATIONAL INC.
804.00
136.60
20.47%
JP:7741
HOYA
23,580.00
3,240.95
15.93%
JP:3046
JINS HOLDINGS
5,740.00
-2,943.93
-33.90%
JP:7780
Menicon Co
1,716.00
631.32
58.20%
JP:5889
Japan Eyewear Holdings Co.,Ltd.
2,255.00
144.43
6.84%
JP:7743
Seed Co., Ltd.
793.00
280.60
54.76%
ASO INTERNATIONAL INC. Corporate Events
ASO International Lifts Profits and Payout While Forecasting Moderate Growth for FY 2027
Aug 7, 2026
ASO International reported consolidated net sales of ¥4.17 billion for the fiscal year ended June 30, 2026, up 9.7% year on year, with operating profit rising 9.9% to ¥723 million and profit attributable to owners of parent climbing 18.2...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.